Mandate

Vinge advises EQT VII in its acquisition of Eton Group AB

December 30, 2015

Vinge advises EQT VII in its acquisition of Eton Group AB and its subsidiaries in Sweden, the US, Canada and the UK (together “Eton”) from Litorina IV and a number of minority shareholders. Founded in Gånghester, Sweden, in 1928, Eton is today a global premium men’s shirts brand, offering shirts and directly linked accessories. Eton primarily sells through department stores, complemented with five own brand stores and its own online store. Eton is still headquartered in Gånghester and has approximately 155 employees across the world. The transaction is conditional upon approval from competition authorities and is expected to close in early 2016.

Vinge’s team consists of partners Christina Kokko and Peter Sundgren together with associates Sofie Bjärtun and Adriana Berglund (both M&A), Karin Virding (IP), Parul Sharma and Linn Gustavsson (both CSR), Karin Isacsson (employment), Nicklas Thorgezon (IT), Jasmin Draszka-Ali, Ulrich Ziche and Maria Dahlin (agreements), Adam Sandberg (financing), Anna Lonergran (real property), Helena Höök (competition law) as well as project assistant Josefin Backlund. Partner Marcus Glader and associates Grant McKelvey and Johanna Bjurling advice in relation to merger filing.

Related

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.
December 10, 2024

Vinge advises Carasent in connection with the listing on Nasdaq Stockholm

Vinge advises Carasent AB (publ) in connection with the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent AB takes over Carasent ASA, previously listed on Oslo Stock Exchange.
December 09, 2024

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.
December 06, 2024